481
Participants
Start Date
August 31, 2007
Primary Completion Date
November 30, 2007
Study Completion Date
November 30, 2007
Placebo nasal spray
Placebo
0.15% azelastine hydrochloride Nasal Spray
0.15% azelastine hydrochloride 822 mcg
AAIR Research Center, Rochester
UPMC-ENT, Pittsburgh
Valley Clinical Research, Easton
Asthma and Allergy Research Associates, Chester
Institute for Asthma and Allergy PC, Wheaton
Chesapeake Clinical Research, Inc, Baltimore
Atlanta Allergy and Asthma Clinic, Woodstock
Clinical Research Atlanta, Stockbridge
Aeroallergy Research Laboratories of Savannah, Savannah
University of South Florida, Tampa
Allergy and Asthma Center of Michigan, Novi
Advanced Healthcare, SC, Milwaukee
Clinical Research Institute, Plymouth
Sneeze, Wheeze and Itch Associates, Normal
The Clinical Research Center, St Louis
Kansas City Allergy and Asthma, Overland Park
The Asthma and Allergy Center, Papillion
Midwest Allergy and Asthma Clinic, Omaha
RX R+D, Metairie
OIAA Clinical Research, LLC, Edmond
Pharmaceutical Research & Consulting Inc, Dallas
Jane Lee, MD, PA Research Center, Dallas
Allergy Asthma Research Institute, Waco
Western Sky Medical Research, El Paso
Colorado Allergy and Asthma centers, PC, Lakewood
Las Vegas Physicians Research Group, Henderson
Allergy, Asthma and Respiratory Care medical Center, Long Beach
Allergy and Asthma Medical Group and Research Center, San Diego
Allergy and Asthma Specialist Medical Group, Huntington Beach
Allergy & Asthma Associates of Santa Clara Valley Research Cntr, San Jose
Bensch Research Associates, Stockton
Allergy and Asthma Research NJ inc, Mount Laurel
Allergy Consultants PA, Verona
Asthma, Nasal Disease & Allergy Research Center of New England, Providence
Lead Sponsor
Meda Pharmaceuticals
INDUSTRY